Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Ainos, Inc.

Market Cap 1.38Cr 1.19Cr 1.1Cr 1.03Cr 1.94Cr 130.9Cr 1.96Cr 13Cr 5.06Cr 64Cr 5.2Cr 5.09Cr 222.15Cr P/E Ratio 2024
-0.29x
P/E Ratio 2025 -0.47x
Enterprise Value 2.44Cr 2.11Cr 1.94Cr 1.82Cr 3.42Cr 230.96Cr 3.45Cr 23Cr 8.92Cr 113.1Cr 9.17Cr 8.97Cr 391.95Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day+2.17%
1 week-7.84%
Current month-21.01%
1 month+10.59%
3 months+31.47%
6 months-12.56%
Current year+14.63%
1 week 1.82
Extreme 1.82
2.01
1 month 1.45
Extreme 1.4513
3.88
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
30.5
5 years 1.26
Extreme 1.26
645
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
05/06Buy

Director

3,500 0.0501%
03/06Buy

Director

2,000 0.0286%
28/05Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%-7.84%-25.34%-89.82% 1.38Cr
-0.23%-4.34%+16.68%-12.04% 18TCr
+0.12%-2.24%-19.65%+26.63% 15TCr
+0.14%-3.75%-9.83%-25.00% 13TCr
+0.34%-4.17%-53.77%-13.62% 6.97TCr
+2.67%+1.19%+18.39%-3.65% 5.1TCr
+0.97%+0.60%-23.33%-33.14% 4.57TCr
-1.72%-5.27%+7.83%+5.95% 3.62TCr
+0.78%-2.86%+3.66%+33.93% 3.54TCr
-2.36%-4.21%-13.22%-19.61% 2.88TCr
Average +0.29%-2.92%-9.86%-13.04% 7.19TCr
Weighted average by Cap. +0.13%-2.86%-7.07%-4.44%

Financials

2024 2025
Net sales 20.73T 17.86T 16.45T 15.45T 29T 19.6L 29.3T 2L 75.73T 10L 77.79T 76.14T 33.26L 1L 1L 98.53T 92.51T 2L 1.17Cr 2L 11.64L 5L 57.48L 5L 5L 1.99Cr
Net income -1.49Cr -1.28Cr -1.18Cr -1.11Cr -2.08Cr -140.52Cr -2.1Cr -14Cr -5.43Cr -69Cr -5.58Cr -5.46Cr -238.48Cr -1.48Cr -1.27Cr -1.17Cr -1.1Cr -2.07Cr -139.65Cr -2.09Cr -14Cr -5.4Cr -68Cr -5.54Cr -5.43Cr -237Cr
Net Debt 81.07L 69.87L 64.34L 60.41L 1.13Cr 77Cr 1.15Cr 7.6Cr 2.96Cr 38Cr 3.04Cr 2.98Cr 130.08Cr 1.06Cr 91.2L 83.98L 78.85L 1.48Cr 100.05Cr 1.5Cr 9.92Cr 3.87Cr 49Cr 3.97Cr 3.89Cr 169.8Cr
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
16/26/16 1.880 $ +2.17% 44,157
15/26/15 1.840 $ -3.66% 56,958
12/26/12 1.910 $ -0.52% 25,852
11/26/11 1.920 $ +1.59% 50,516
10/26/10 1.890 $ -7.35% 27,101
  1. Stock Market
  2. Stocks
  3. AIMD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!